cations of hypertension, obesity, diabetes, and, in postmenopausal women, hormonal changes, all of which increase the risk of myocardial infarction, call for an integrated approach to prevention and treatment.
In 1990 diseases of the heart and vascular system were responsible for the deaths of more than 900 000 Americans,l or for about 43% of all deaths. The economic cost of these diseases in the United States in 1993 is estimated to be more than $117 billion.' This figure includes physician and nursing services, hospital and nursing home services, the cost of medication, and lost productivity due to disability.
In the United States 571 000 operations were performed on the vascular system in 1985. In addition to surgical treatment of the epicardial coronary arteries, these operations included 107 000 carotid endarterectomies, 72 000 popliteal and tibial artery bypasses, 55 000 angiographic procedures, 33 000 abdominal aortic aneurysm repairs, and 30 000 aortoiliofemoral reconstruc- tions.' In addition to surgical treatment of varicose veins, 6 million episodes of deep vein thrombosis and 500 000 episodes of pulmonary embolism with 50 000 deaths were recorded in 1989.3 In 1989 in the United States there were 400 000 first strokes and 100 000 recurrent strokes. Brain infarction due to thromboembolism is the most common type of stroke, particularly in the elderly. In one population aged 55 years and older, the proportion of thromboembolic strokes increased from 71% in 1945 through 1949 to 81% in 1980 through 1984.'
The incidence of arterial disease in the large leg arteries increases dramatically with age. A series of noninvasive tests on a population of 624 men and women in Southern California (average age, 66 years) showed that 11.7% had arterial disease of the large leg arteries (almost half of these subjects also had disease of the smaller arteries) and 16% had isolated disease of the small leg arteries. The preclinical curriculum for medical students should emphasize the molecular and cellular bases of vascular disease and the risk factors leading to it. This would entail focusing on molecular programming of the vascular system, signal transduction and gene transcription, and molecular defects and the possibilities of gene therapy.
